Cargando…

Ductal closure using the Amplatzer duct occluder type two: experience in Port Elizabeth hospital complex, South Africa

OBJECTIVE: To report outcomes in percutaneous ductal closure using the Amplatzer duct occluder type two (ADO II). METHODS: Records of patients admitted for percutaneous closure of patent ductus arteriosus (PDA) were reviewed. RESULTS: From May 2009 to July 2012, 36 patients were assigned to closure...

Descripción completa

Detalles Bibliográficos
Autores principales: Pepeta, Lungile, Dippenaar, Adele
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Clinics Cardive Publishing 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986386/
https://www.ncbi.nlm.nih.gov/pubmed/23812377
http://dx.doi.org/10.5830/CVJA-2013-033
Descripción
Sumario:OBJECTIVE: To report outcomes in percutaneous ductal closure using the Amplatzer duct occluder type two (ADO II). METHODS: Records of patients admitted for percutaneous closure of patent ductus arteriosus (PDA) were reviewed. RESULTS: From May 2009 to July 2012, 36 patients were assigned to closure using the ADO II. There were 21 females and 15 males. The median age was 16.5 (2–233) months; median weight, 8 (3.94–39.2) kg; and median height, 75 (55–166) cm. The mean pulmonary artery pressure was 24.4 (± 10.4) mmHg, the pulmonary blood flow:systemic blood flow (Qp:Qs) ratio was 2.25 (± 1.97), and mean pulmonary resistance (Rp) was 1.87 (± 1.28) Wood units. The mean ductal size was 2.74 (± 1.3) mm. In 30 patients the device was delivered through the pulmonary artery. Thirty-three patients achieved complete closure by discharge (day one). CONCLUSION: The ADO II is capable of closing a wide range of ducts in carefully selected patients. Our findings are comparable with other studies regarding ductal closure rates.